Travis Alan Coy - 17 Feb 2026 Form 4 Insider Report for Immunocore Holdings plc (IMCR)

Reporting relationship: Chief Financial Officer
Issuer ticker: IMCR
Reported as of: 17 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Feb 2026, 17:00:28 UTC
Prior SEC filing: 03 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Lily Hepworth, Attorney-in-Fact

Key filing fact

Travis Alan Coy filed Form 4 for Immunocore Holdings plc (IMCR) on 19 Feb 2026.

Key facts

This page summarizes Travis Alan Coy's Form 4 filing for Immunocore Holdings plc (IMCR).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 19 Feb 2026, 17:00.

Change

Previous filing in this sequence was filed on 03 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001969524 Primary reporting owner

Coy Travis Alan

Relationship: Chief Financial Officer
Address: C/O IMMUNOCORE HOLDINGS PLC, 92 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, UNITED KINGDOM
Signature: /s/ Lily Hepworth, Attorney-in-Fact
Signature date: 19 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMCR transaction Derivative

Restricted Share Units

Award

Transaction value: $0
Shares: +33,353
Change %
Price: $0.000000
Shares after: 33,353
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 33,353
Exercise price
Footnotes: F1, F2, F3

IMCR transaction Derivative

Employee Share Option (Right to Buy)

Award

Transaction value: $0
Shares: +95,637
Change %
Price: $0.000000
Shares after: 95,637
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 95,637
Exercise price: $32.38
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted share unit ("RSU") represents a contingent right to receive one Ordinary Share.

Footnote F2

The RSUs vest in four equal annual installments beginning February 17, 2027, subject to the Reporting Person's continuous service through each such vesting date.

Footnote F3

Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share.

Footnote F4

25% of the shares subject to the option award shall vest on February 17, 2027, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.